Literature DB >> 22290834

Intraosseous carcinoma of the jaws: a clinicopathologic review. Part II: Odontogenic carcinomas.

Julia A Woolgar1, Asterios Triantafyllou, Alfio Ferlito, Kenneth O Devaney, James S Lewis, Alessandra Rinaldo, Pieter J Slootweg, Leon Barnes.   

Abstract

This is the second of a 3-part review of the clinicopathologic features of intraosseous carcinoma of the jaws (IOCJ). This part deals with odontogenic carcinomas, rare entities that are difficult to evaluate because of changes in classification/nomenclature, lack of standardized diagnostic criteria, and variable consistency of the existing literature. Endorsing a critical approach, problems are addressed and areas of uncertainty are highlighted. As in part I, we emphasize histopathologic features from a diagnostic point of view and also question the existence of some "distinct" entities.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22290834     DOI: 10.1002/hed.22923

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  4 in total

1.  Double reporting and second opinion in head and neck pathology.

Authors:  Julia A Woolgar; Asterios Triantafyllou; Lester D R Thompson; Jennifer L Hunt; James S Lewis; Michelle D Williams; Antonio Cardesa; Alessandra Rinaldo; Leon Barnes; Pieter J Slootweg; Kenneth O Devaney; Douglas R Gnepp; William H Westra; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-01-17       Impact factor: 2.503

Review 2.  Malignant odontogenic tumors: an update on selected tumors.

Authors:  Mary S Richardson; Susan Muller
Journal:  Head Neck Pathol       Date:  2014-11-20

3.  Maxillary ameloblastic carcinoma: A diagnostic conundrum.

Authors:  Manisha Shrikaar; S Suwasini; Kabita Chatterjee; Shuchita Sinha
Journal:  J Oral Maxillofac Pathol       Date:  2021-05-14

4.  Clear cell odontogenic carcinoma of the mandible: a treatment strategy.

Authors:  Sabrina Ferreira; Leonardo Perez Faverani; Gabriel Mulinari Dos Santos; Everton Pontes Martins; Idelmo Rangel Garcia Júnior
Journal:  J Appl Oral Sci       Date:  2018-01-15       Impact factor: 2.698

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.